Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata, Ann‐Lii Cheng, Norihiro Kokudo, et al.
Hepatology International (2017) Vol. 11, Iss. 4, pp. 317-370
Open Access | Times Cited: 1890

Showing 26-50 of 1890 citing articles:

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Josep M. Llovet, Augusto Villanueva, Jorge A. Marrero, et al.
Hepatology (2020) Vol. 73, Iss. S1, pp. 158-191
Open Access | Times Cited: 322
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 290
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, et al.
Nature Cancer (2022) Vol. 3, Iss. 4, pp. 386-401
Open Access | Times Cited: 286
Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma
Joseph Ahn, Pai‐Chi Teng, Pin‐Jung Chen, et al.
Hepatology (2020) Vol. 73, Iss. 1, pp. 422-436
Open Access | Times Cited: 279
A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
Li Yang, Dongsheng Gu, Jingwei Wei, et al.
Liver Cancer (2018) Vol. 8, Iss. 5, pp. 373-386
Open Access | Times Cited: 270
Recent progress in treatment of hepatocellular carcinoma.
Zhiqian Chen, Hao Xie, Mingming Hu, et al.
PubMed (2020) Vol. 10, Iss. 9, pp. 2993-3036
Closed Access | Times Cited: 262
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1084-1084
Open Access | Times Cited: 253
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Shukui Qin, Minshan Chen, Ann‐Lii Cheng, et al.
The Lancet (2023) Vol. 402, Iss. 10415, pp. 1835-1847
Closed Access | Times Cited: 244
Lenvatinib: A Review in Hepatocellular Carcinoma
Zaina T. Al-Salama, Yahiya Y. Syed, Lesley J. Scott
Drugs (2019) Vol. 79, Iss. 6, pp. 665-674
Closed Access | Times Cited: 242
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
Masatoshi Kudo, Kwang–Hyub Han, Sheng-Long Ye, et al.
Liver Cancer (2020) Vol. 9, Iss. 3, pp. 245-260
Open Access | Times Cited: 240
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology (2019) Vol. 20, Iss. 7, pp. 1042-1042
Open Access | Times Cited: 221
Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis
Atsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji, et al.
Liver Cancer (2018) Vol. 8, Iss. 2, pp. 121-129
Open Access | Times Cited: 205
Current epidemiology in hepatocellular carcinoma
Peter Konyn, Aijaz Ahmed, Donghee Kim
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 11, pp. 1295-1307
Closed Access | Times Cited: 200
Hepatocellular carcinoma surveillance: An evidence-based approach
Patrick Harris, Ross M Hansen, Meagan Gray, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 13, pp. 1550-1559
Open Access | Times Cited: 198
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 583-705
Open Access | Times Cited: 193
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
L.-T. Chen, Erika Martinelli, Ann‐Lii Cheng, et al.
Annals of Oncology (2020) Vol. 31, Iss. 3, pp. 334-351
Open Access | Times Cited: 191
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Jian Zhou, Hui‐Chuan Sun, Zheng Wang, et al.
Liver Cancer (2023) Vol. 12, Iss. 5, pp. 405-444
Open Access | Times Cited: 191
IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation
Stephen P. Hack, Jessica Spahn, Minshan Chen, et al.
Future Oncology (2020) Vol. 16, Iss. 15, pp. 975-989
Open Access | Times Cited: 182
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae Hyung Kim, So Yeon Kim, An Tang, et al.
Clinical and Molecular Hepatology (2019) Vol. 25, Iss. 3, pp. 245-263
Open Access | Times Cited: 178
Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging
Jie Peng, Shuai Kang, Zhengyuan Ning, et al.
European Radiology (2019) Vol. 30, Iss. 1, pp. 413-424
Open Access | Times Cited: 175
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
QiJiong Li, Minke He, Huanwei Chen, et al.
Journal of Clinical Oncology (2021) Vol. 40, Iss. 2, pp. 150-160
Closed Access | Times Cited: 173
Recent advances in development of dendritic polymer‐based nanomedicines for cancer diagnosis
Haonan Li, Jiayu Sun, Hongyan Zhu, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2020) Vol. 13, Iss. 2
Closed Access | Times Cited: 171
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score
Ju Dong Yang, Benyam D. Addissie, Kristin C. Mara, et al.
Cancer Epidemiology Biomarkers & Prevention (2018) Vol. 28, Iss. 3, pp. 531-538
Open Access | Times Cited: 169
Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma
Xiaoli Liu, Mengge Li, Xinhui Wang, et al.
Phytomedicine (2019) Vol. 62, pp. 152930-152930
Open Access | Times Cited: 169
Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data
Shihui Zhen, Ming Cheng, Yu-bo Tao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 167

Scroll to top